Boardroom Alpha
Meeting calendar
BHR · Annual meeting · Monday, December 21, 2026Contested

Braemar Hotels & Resorts Inc

13 nominees · 4 ballot items · contested.

The meeting will vote on the contested election of eight directors, ratification of BDO USA, P.C. as independent auditor, advisory approval of named executive officer compensation, and any other properly presented business.

Market cap
$119M
1Y TSR
-43.7%
Board grade
C-
Record date
Sep 30, 2026
Filing
DEFC14A
Filed Nov 4, 2026 · DEFC14A
Proposals

On the ballot4

  1. 1

    Election of Eight Directors

    Shareholder — Brancous, LP1 and the other Participants in its solicitation

    Elect eight directors to serve until the 2027 annual meeting and until their successors are elected and qualify; the proxy solicits votes for five Brancous nominees and recommends withholding votes from the eight Company nominees, with up to eight candidates selectable.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    Management

    Ratify the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

  3. 3

    Advisory Vote on Executive Compensation

    Management

    Approve, on an advisory basis, the compensation of the Company’s named executive officers.

    More detail

    Proposal 3 asks stockholders to provide an advisory vote approving the compensation of Braemar’s named executive officers. The proposal is a management-originated say-on-pay matter, although the insurgent proxy statement does not reproduce the Company’s detailed compensation discussion or resolution language beyond its short description. The vote is advisory and therefore does not directly bind the Board or alter executive compensation contracts. The filing provides no specific compensation metrics, pay outcomes, performance goals, or changes to incentive arrangements. It also does not identify any transaction-specific compensation issue tied to the Ashford advisory relationship or the Company’s asset-sale program. Brancous expressly makes no recommendation on the proposal, leaving stockholders without a voting position from the soliciting shareholder in this filing. The Company’s own proxy statement is expected to supply the fuller rationale, compensation tables, and management recommendation. If an unmarked Blue proxy card is returned, the shares will be voted “ABSTAIN” on Proposal 3. Because abstentions are not votes cast, the filing states that they will have no effect on the outcome, although they count toward a quorum.

  4. 4

    Other Business

    Management

    Transact any other business that may properly come before the Annual Meeting.

    More detail

    The proxy includes a standard catch-all matter authorizing consideration of other business that may properly come before the Annual Meeting. No separate proposal, business item, or resolution is identified in the filing. The soliciting participants state that they are not aware of any additional matters beyond Proposals 1 through 3. If an unknown matter is properly presented, the named proxies may vote in their discretion to the extent permitted by Rule 14a-4(c)(3) under the Exchange Act. The filing does not describe any substantive issue, governance change, transaction, or compensation consequence associated with this item. It therefore functions primarily as a proxy-voting authorization for unforeseen procedural or substantive matters. No management or shareholder recommendation is provided for an unidentified matter. The filing also states that the proxies may vote on matters incident to conducting the Annual Meeting as permitted by Rule 14a-4(c)(7).

Director elections

Nominees on the ballot13

Oliver Corlette
Independent
Tenure on this board
New nominee
Ronald Davies
Independent
Tenure on this board
New nominee
Andrew Fleiss
Independent
Tenure on this board
New nominee
Michael Litwin
Independent
Tenure on this board
New nominee
Alejandro Malbran
Not independent
Tenure on this board
New nominee
Not independent
Tenure on this board
0.1 yrs
Also a director at
Sabra Health Care REIT Inc (SBRA)Evolent Health Inc (EVH)
Not independent
Tenure on this board
0.1 yrs
Also a director at
Macerich Co (MAC)
Not independent
Tenure on this board
0.1 yrs
Also a director at
Federal Realty Investment Trust (FRT)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.5.4%3,705,835$8M
2VANGUARD CAPITAL MANAGEMENT LLC4.0%2,737,146$6M
3BlackRock, Inc.3.9%2,705,629$6M
4ZAZOVE ASSOCIATES LLC3.2%2,217,055$5M
5BlackRock, Inc.2.8%1,929,746$4M
6LSV ASSET MANAGEMENT2.5%1,710,389$4M
7STATE STREET CORP1.9%1,312,676$3M
8GEODE CAPITAL MANAGEMENT, LLC1.9%1,285,659$3M
9ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.7%1,142,971$2M
10LANDMARK INVESTMENT PARTNERS, L.P.1.4%988,883$2M
Filings

Braemar Hotels & Resorts Inc proxy statements and SEC reports

Annual & quarterly reports (10-K, 10-Q)
Proxy statements (DEF 14A)
Reference

Frequently asked questions

When is the Braemar Hotels & Resorts Inc 2026 annual meeting?
Braemar Hotels & Resorts Inc (BHR) holds its 2026 annual shareholder meeting on Monday, December 21, 2026.
What is the record date for the Braemar Hotels & Resorts Inc 2026 meeting?
The record date for the Braemar Hotels & Resorts Inc 2026 meeting is Wednesday, September 30, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Braemar Hotels & Resorts Inc's 2026 meeting?
The board is presenting 13 director nominees at the Braemar Hotels & Resorts Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Braemar Hotels & Resorts Inc 2026 meeting?
Shareholders will vote on 4 proposals at the Braemar Hotels & Resorts Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer